Genital human papillomavirus infections: current and prospective therapies
MA Stanley - Journal of general virology, 2012 - microbiologyresearch.org
Infection with human papillomaviruses (HPVs) is very common and associated with benign
and malignant epithelial proliferations of skin and internal squamous mucosae. A subset of …
and malignant epithelial proliferations of skin and internal squamous mucosae. A subset of …
Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer
MP Morrow, J Yan, NY Sardesai - Expert review of vaccines, 2013 - Taylor & Francis
Infections with oncogenic HPV types have the potential to lead to the induction of several
types of cancer, notably cervical, vulvar, anal, and head and neck cancer. While prophylactic …
types of cancer, notably cervical, vulvar, anal, and head and neck cancer. While prophylactic …
Immunobiology of HPV and HPV vaccines
M Stanley - Gynecologic oncology, 2008 - Elsevier
Genital human papillomavirus (HPV) infection with both low-and high-risk types is common,
but most infections resolve as a result of a cell-mediated immune response. Failure to …
but most infections resolve as a result of a cell-mediated immune response. Failure to …
Emerging human papillomavirus vaccines
ND Christensen - Expert Opinion on Emerging Drugs, 2005 - Taylor & Francis
Human papillomavirus (HPV) infections are a leading cause of virus-associated cancers of
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination
PL Stern - Journal of clinical virology, 2005 - Elsevier
This review discusses:(1) immune mechanisms relevant to the natural control of a human
papillomavirus (HPV) infection;(2) viral strategies to evade or subvert immune attack;(3) the …
papillomavirus (HPV) infection;(2) viral strategies to evade or subvert immune attack;(3) the …
Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease
AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Carcinomas of the anogenital tract, in particular cervical cancer, remains one of the most
common cancers in women, and represent the most frequent gynecological malignancies …
common cancers in women, and represent the most frequent gynecological malignancies …
Vaccines against human papillomavirus and cervical cancer: promises and challenges
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …
Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …